e-learning
resources
Paris 2018
Monday, 17.09.2018
Chronic pulmonary aspergillosis: from guidelines to real-life implementation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Achieving consensus regarding the current treatment options for CPA
C. Godet (Poitiers, France)
Source:
International Congress 2018 – Chronic pulmonary aspergillosis: from guidelines to real-life implementation
Session:
Chronic pulmonary aspergillosis: from guidelines to real-life implementation
Session type:
Hot topics
Number:
3242
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Godet (Poitiers, France). Achieving consensus regarding the current treatment options for CPA. International Congress 2018 – Chronic pulmonary aspergillosis: from guidelines to real-life implementation
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Treatment options and recommendations
Source: International Congress 2019 – European guidelines for malignant pleural mesothelioma management in 2019
Year: 2019
Treatment options and recommendations
Source: Virtual Congress 2021 – ERS clinical practice guidelines on treatment of sarcoidosis
Year: 2021
Treatment options and recommendations
Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis
Year: 2021
Treatment options and recommendations
Source: Virtual Congress 2021 – ERS guidelines on non-continuous positive airway pressure therapies in obstructive sleep apnoea
Year: 2021
ERS guidelines: treatment options and recommendations
Source: International Congress 2019 – Guidelines for long-term non-invasive ventilation in chronic obstructive pulmonary disease
Year: 2019
Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
A new definition of multimodality treatment
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016
Other options of prevention - the current state and the future
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007
Therapeutic strategies: what treatment for what patient
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008
From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017
What is the difference between an evidence-based guideline and a consensus statement?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006
Overall treatment strategies
Source: Eur Respir Monogr 2015; 67: 305-325
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept